EAM
NVAX icon

Eagle Asset Management’s Novavax NVAX Stock Holding History

Eagle Asset Management’s Portfolio NVAX Stock Details NVAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-139,518
Closed -$25.9M – 612
2021
Q1 		$25.9M Buy
139,518
+17,020
+14% +$3.39M 0.11% 217
2020
Q4 		$13.7M Sell
122,498
-9,153
-7% -$973K 0.08% 253
2020
Q3 		$14.2M Buy
+131,651
New +$16M 0.07% 239
2018
Q3 		– Sell
-62,526
Closed -$1.68M – 628
2018
Q2 		$1.68M Buy
+62,526
New +$2.11M 0.01% 535
2016
Q3 		– Sell
-251,610
Closed -$36.6M – 655
2016
Q2 		$36.6M Sell
251,610
-10,546
-4% -$1.21M 0.25% 125
2016
Q1 		$27.1M Buy
262,156
+180,762
+222% +$19.4M 0.19% 169
2015
Q4 		$13.7M Buy
81,394
+40,109
+97% +$6.17M 0.09% 287
2015
Q3 		$5.84M Buy
+41,285
New +$9.26M 0.04% 394

Other funds holding NVAX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Eagle Asset Management's NVAX Position: Q2 2021 in Review

Eagle Asset Management sold out of Novavax (NVAX) in Q2 2021, closing a stake of 139,518 shares — an estimated $25.9M sold.

Eagle Asset Management first reported a position in NVAX in Q3 2015 and held it in 8 quarters. The position peaked at $36.6M in Q2 2016. 407 funds tracked by Wall St. Rank hold NVAX as of Q2 2021.

  • Eagle Asset Management reported no remaining Novavax position as of Q2 2021 after selling out during the quarter.
  • Eagle Asset Management sold 139,518 Novavax shares in Q2 2021, an estimated $25.9M.
  • Eagle Asset Management first reported a position in Novavax in Q3 2015 and held it in 8 quarters.
  • Eagle Asset Management's Novavax position peaked at $36.6M in Q2 2016.
  • 407 funds tracked by Wall St. Rank held Novavax as of Q2 2021.

Based on Eagle Asset Management's 13F filing for Q2 2021, filed 11 Aug 2021.